Familial Mediterranean Fever (FMF) - Diagnosis and ...

Familial Mediterranean Fever (FMF) - Diagnosis and Management Summary

Autoinflammatory disorder due to mutations in MEFV gene; autosomal recessive

inheritance; characterized by recurrent bouts of fever and serosal inflammation

 • Epi: Most common in Jews, Armenians, Turks, and Arabs. Onset <10 yrs old (65% pts), <20 yrs old (90% pts)

 • Sx: Recurrent acute attacks (1-3 days, resolve spontaneously) of fever associated w/ peritonitis (often mistaken for surgical abdomen), unilateral pleuritis, arthritis (monoarticular, sterile joint), or skin lesions (erysipelas-like). Other manifestations include: exertional myalgia, pericarditis, testicular pain, and aseptic meningitis.

    o Long-term complications: Secondary (AA) amyloidosis: renal disease (major cause of mortality), SBO, infertility

 • Dx: During acute attack: ↑ WBC, ↑ ESR/CRP. Check UA for amyloidosis (proteinuria). Genetic testing for confirmation.

    o Diagnostic criteria: Livenh et al. Requires 1 major or 2 minor criteria. (Arthritis Rheum 1997; 40:1879)

 • Rx: Colchicine 1-3 mg/day (to prevent acute attacks and progression to amyloidosis). 5-10% colchicine resistant, add on IL-1 inhibitors.

#Familial #Mediterranean #Fever #FMF #Diagnosis #Management #treatment #rheumatology 
Contributed by

MGH White Book Manual
Account created for the MGH Internal Medicine Housestaff Manual "White Book" - https://stk10.github.io/MGH-Docs/WhiteBook-2019-2020.pdf

Related content